Drug Pricing

Pfizer reorg came on heels of its walk-back on price hikes

Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey

Three quarters of Americans support listing drug prices in DTC ads: Kaiser survey

By

Across the political spectrum, most Americans favor President Donald Trump's proposal to show drug prices in advertisements.